Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BY-NC-NDPlastic and Reconstructive Surgery, Global Open

Biopsy of Secondary Angiosarcoma Arising in Native Mastectomy Skin of a Reconstructed Breast Without Prior Radiotherapy

  1. 1From the * Department of Plastic and Reconstructive Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
  2. 2‡ Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  3. 3† Department of Plastic and Reconstructive Surgery, Nippon Medical School, Tokyo, Japan

Abstract

Secondary breast angiosarcoma usually develops after radiotherapy or in the setting of chronic lymphedema. We report a rare case of non-radiation-associated secondary cutaneous angiosarcoma arising in the native mastectomy skin overlying a reconstructed breast after immediate tissue expander placement and delayed deep inferior epigastric perforator flap reconstruction for breast cancer. The patient’s clinical course, imaging, histopathological findings, and treatment were retrospectively reviewed. The clinicopathological features were compared with previously reported cases of angiosarcoma arising after breast reconstruction without radiotherapy before angiosarcoma onset. A 45-year-old woman underwent right mastectomy, axillary dissection, and immediate tissue expander placement for right breast cancer (T2N1M0, stage IIB), followed by delayed deep inferior epigastric perforator flap reconstruction 1 year later. No adjuvant radiotherapy was administered. Three years after the initial breast cancer surgery, progressive purpura and dark violaceous nodules developed in the native mastectomy skin. Skin biopsy confirmed cutaneous angiosarcoma. Histology showed atypical endothelial proliferation forming irregular vascular channels; tumor cells were positive for ETS-related gene and cluster of differentiation 34; the molecular immunology borstel-1 index was approximately 40%; and MYC proto-oncogene expression was observed in 60%–70% of tumor cells. Positron emission tomography–computed tomography showed no distant metastasis. Because the cutaneous disease was diffuse and surgical local control was judged difficult, multimodal treatment with pazopanib and radiotherapy (70 Gy) was initiated, followed by trastuzumab plus paclitaxel for local progression. No distant metastasis was present at the latest follow-up, although local control remained challenging. Persistent or progressive dermatitis-like lesions in postmastectomy breast skin should prompt early biopsy even in patients without prior radiotherapy.

Related

  1. Advances in Implant-Based Breast Reconstruction in the Setting of Post-Mastectomy Radiotherapy
    Qingyu Wang, Bingyue Li, Siyu Chen +1
    Aesthetic Plastic SurgeryPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  2. Secondary breast surgery after initial partial mastectomy for breast cancer in Japan
    Munetsugu Hirata, Yuko Kijima, Sam E. Wing +2
    Surgery TodayPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Efficacy and safety of stereotactic body radiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis.
    Pengfei Ji, Zhihui Zhao, Xinpu Tang +7
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Age and the association of radiotherapy with survival in extensive-stage small-cell lung cancer: an exploratory secondary analysis of two observational cohorts.
    Shengxin Zhang, Yang Liu, Xueyan Zhou +9
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Case Report: Primary epithelioid angiosarcoma of the femur: two rare cases with atypical skeletal involvement
    Fangfang Xu, Min Xu, Qian Li +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{minakamegai2026biopsy,
  title = {{Biopsy of Secondary Angiosarcoma Arising in Native Mastectomy Skin of a Reconstructed Breast Without Prior Radiotherapy}},
  author = {Mina Kamegai, MD and Yohei Iwanaga, MD and Shoichi Tomita, MD, PhD and Miwako Fujii, MD and Keisuke Goto, MD and Tsunekazu Hishima, MD and Rei Ogawa, MD, PhD and Yasunobu Terao, MD, PhD},
  journal = {Plastic and Reconstructive Surgery, Global Open},
  year = {2026},
  month = oct,
  doi = {10.1097/gox.0000000000008171},
  url = {https://doi.org/10.1097/gox.0000000000008171},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Biopsy of Secondary Angiosarcoma Arising in Native Mastectomy Skin of a Reconstructed Breast Without Prior Radiotherapy
AU  - Mina Kamegai, MD
AU  - Yohei Iwanaga, MD
AU  - Shoichi Tomita, MD, PhD
AU  - Miwako Fujii, MD
AU  - Keisuke Goto, MD
AU  - Tsunekazu Hishima, MD
AU  - Rei Ogawa, MD, PhD
AU  - Yasunobu Terao, MD, PhD
PY  - 2026
DA  - 2026/10/29
JO  - Plastic and Reconstructive Surgery, Global Open
DO  - 10.1097/gox.0000000000008171
UR  - https://doi.org/10.1097/gox.0000000000008171
AB  - Secondary breast angiosarcoma usually develops after radiotherapy or in the setting of chronic lymphedema. We report a rare case of non-radiation-associated secondary cutaneous angiosarcoma arising in the native mastectomy skin overlying a reconstructed breast after immediate tissue expander placement and delayed deep inferior epigastric perforator flap reconstruction for breast cancer. The patient’s clinical course, imaging, histopathological findings, and treatment were retrospectively reviewed. The clinicopathological features were compared with previously reported cases of angiosarcoma arising after breast reconstruction without radiotherapy before angiosarcoma onset. A 45-year-old woman underwent right mastectomy, axillary dissection, and immediate tissue expander placement for right breast cancer (T2N1M0, stage IIB), followed by delayed deep inferior epigastric perforator flap reconstruction 1 year later. No adjuvant radiotherapy was administered. Three years after the initial breast cancer surgery, progressive purpura and dark violaceous nodules developed in the native mastectomy skin. Skin biopsy confirmed cutaneous angiosarcoma. Histology showed atypical endothelial proliferation forming irregular vascular channels; tumor cells were positive for ETS-related gene and cluster of differentiation 34; the molecular immunology borstel-1 index was approximately 40%; and MYC proto-oncogene expression was observed in 60%–70% of tumor cells. Positron emission tomography–computed tomography showed no distant metastasis. Because the cutaneous disease was diffuse and surgical local control was judged difficult, multimodal treatment with pazopanib and radiotherapy (70 Gy) was initiated, followed by trastuzumab plus paclitaxel for local progression. No distant metastasis was present at the latest follow-up, although local control remained challenging. Persistent or progressive dermatitis-like lesions in postmastectomy breast skin should prompt early biopsy even in patients without prior radiotherapy.
SN  - 2169-7574
ER  -